|
|
|
Vol. 13, No. 15, pp. 1918-1923, August 1, 1999
1 Howard Hughes Medical Institute, 2 Department of Genetics, 3 Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115 USA; 4 National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892-0460 USA
| |
Abstract |
|---|
|
|
|---|
The mammalian Daxx gene has been identified in a diverse set of yeast interaction trap experiments. Although a facilitating role for Daxx in Fas-induced apoptosis has been suggested, Daxx's physiologic function remains unknown. To elucidate the in vivo role of Daxx, we have generated Daxx-deficient mice. Surprisingly, rather than a hyperproliferative disorder expected from the loss of a pro-apoptotic gene, mutation of Daxx results in extensive apoptosis and embryonic lethality. These findings argue against a role for Daxx in promoting Fas-induced cell death and suggest that Daxx either directly or indirectly suppresses apoptosis in the early embryo.
| |
Introduction |
|---|
|
|
|---|
Daxx is a 120-kD protein that has been
identified in several yeast interaction trap systems using a variety of
different "baits" (Kiriakidou et al. 1997
; Yang et al. 1997
; Pluta
et al. 1998
). Because this set of interacting proteins appears so
diverse, it has been difficult to evaluate the physiologic significance
of these interactions. The highly conserved Daxx gene has a
ubiquitous expression pattern (Kiriakidou et al. 1997
; Yang et al.
1997
) and is not a member of any previously identified families of
proteins. Given the variety of observed interactions, including a novel one described here, the functional significance of these and, hence,
the physiologic role of Daxx remains in doubt.
Daxx was first reported as a protein that associates with the
intracellular domain of Fas in an interaction trap system in yeast
(Yang et al. 1997
). Furthermore, Yang et al. demonstrated that Daxx
enhanced Fas-mediated apoptosis when the two proteins were coordinately
overexpressed. They also showed that this apoptosis was dependent on
the Jun amino-terminal kinase (JNK) pathway. Specifically, Daxx was
shown to function by activating the JNK kinase kinase, ASK1, in
cotransfection assays (Chang et al. 1998
). Previously, Fas was shown to
bind FADD (Mort 1) via its cytoplasmic domain (Boldin et al. 1995
;
Chinnaiyan et al. 1995
) and activate pro-caspase-8 (Boldin et al. 1996
;
Muzio et al. 1996
), thereby initiating the caspase cascade.
Interestingly, cells deficient in FADD or caspase-8 are resistant to
death induction through Fas (Juo et al. 1998
; Yeh et al. 1998
; Zhang et
al. 1998
), implying that Daxx should not be sufficient for induction of
apoptosis. Moreover, a cell line expressing a mutant version of Fas
unable to bind FADD (Fas
) is insensitive to the
induction of apoptosis through Fas despite the ability of
Fas
to bind Daxx (Chang et al. 1999
). Although
Fas
-expressing cells cannot undergo Fas-induced apoptosis, they nonetheless retain the ability to induce JNK activity (Chang et al. 1999
).
Although its initial identification placed Daxx in the Fas pathway,
Daxx has also been identified in additional interaction trap system
studies using bait proteins that appear to be unrelated to Fas-induced
apoptosis. For example, Kiriakidou et al. (1997)
cloned monkey and
human DAXX in a search for transcription factors that regulate
the promoter of the steroidogenic acute regulatory protein gene. An
additional group identified Daxx as interacting with CENP-C, an
intrinsic protein of the human centromere thought to be crucial for
chromosome segregation and mitotic progression (Pluta et al. 1998
). Our
laboratory has now identified Daxx in association with yet another
protein, DNA methyltransferase I.
To directly assess the significance of these various interactions and
to learn the in vivo role of Daxx, we have used targeted disruption to
create a null mutation of the mouse Daxx gene by homologous
recombination in embryonic stem (ES) cells. Our results demonstrate
that a deficiency in Daxx results in embryonic lethality by day 9.5 of
gestation. Furthermore, in contrast to what might have been expected
given the proposed role of Daxx in promoting apoptosis, this lethality
is marked by significant apoptosis evident in Daxx-deficient embryos by
day 7.5. Consistent with this, increased levels of apoptosis are also
apparent in Daxx
/
cell lines.
Our results thus indicate that Daxx is an essential gene in mouse
development and plays a role
either directly or indirectly
in
preventing apoptosis.
| |
Results and Discussion |
|---|
|
|
|---|
Targeted disruption of the Daxx gene results in embryonic lethality
Because of our long-standing interest in genetic imprinting, we came upon Daxx while using a yeast two-hybrid system to screen a HeLa cell library for proteins that interact with DNA methyltransferase I (data not shown). Because Daxx had been shown to interact in this system with several other proteins, we hoped to gain insight into its in vivo function by targeting the Daxx locus using homologous recombination.
Accordingly, the genomic locus of Daxx was cloned from a
129/SV female liver library and found to be composed of
seven exons (Fig. 1A). This gene was localized to a
position on mouse chromosome 17 within the MHC with the following
gene order and recombinational distances:
C-Pim1-4.4 ± 2.1-Daxx-1.1 ± 1.1-Notch4-1.4 ± 1.4-Tnf. This region is homologous to human chromosome 6p21.3, to which the
human DAXX gene has been mapped previously (Kiriakidou et al.
1997
). A targeting construct was generated in the pPNT vector, whereby
a neoR cassette in the reverse orientation replaced
2.5 kb of the Daxx locus, including exon I, intron I, and a
major portion of exon II (Fig. 1A). Following transfection of the
construct into TC1 ES cells (Deng et al. 1996
) and selection in G418
and FIAU, 126 colonies were picked, 7 of which had undergone homologous
recombination at the Daxx locus. Injection of a heterozygous
ES clone into blastocysts resulted in the generation of
germ-line-competent chimeras, which were subsequently bred with
129/SvEv mice. Genotypic analysis following mating of
heterozygous mice revealed that of several hundred F2
generation progeny examined, none was homozygous for the Daxx
mutation. Daxx heterozygous animals were present in expected ratios,
and the heterozygotes appeared phenotypically normal. Based on these
findings, we presumed that homozygous mutants were dying during
embryonic development.
|
Early lethality of Daxx mutants is characterized by extensive apoptosis
To establish the developmental stage at which Daxx homozygous embryos die, genotypic analyses of timed matings were performed. A PCR assay was employed for genotyping the embryos (Fig. 1B). As early as E9.5, no mutant embryos were detected, indicating that they were dying prior to this stage. Mutant embryos were evident at E8.5, although in lower than expected ratios. In an attempt to suppress or at least ameliorate the lethal phenotype, the Daxx mutation was crossed onto an outbred background by breeding Daxx heterozygotes (129/SvEv) with Black Swiss (BLKSW) mice. Outbred homozygous mutant embryos were identified at E9.5, although not later, demonstrating a slightly increased viability on the outbred background. Except as noted otherwise, further studies of mutant embryos were performed on outbred crosses.
Morphologic analysis of whole embryos revealed that early in development, mutant embryos are readily distinguishable from their wild-type and heterozygous counterparts. At E7.5, the mutant embryos are significantly smaller and highly disorganized (data not shown). By E8.5 and E9.5 the decreased size and extensive disorganization of the mutant relative to the wild-type embryos is dramatic (Fig. 2A). At these later stages, it is possible to distinguish mutants from their littermates based on the smaller size of the deciduae (Fig. 2B).
|
Histologic analysis was performed to further characterize the mutant embryos. Paraffin-embedded fixed sections derived from E7.5 and E8.5 embryos were examined following staining with hematoxylin and eosin. At E7.5, mutant embryos are markedly reduced in size and highly disorganized as compared to wild-type and heterozygous littermates (Fig. 2C). In the mutant embryo, the ectoderm-derived cells fail to organize as a uniform layer but, rather, remain as a clump of cells; in a heterozygous littermate, formation of the neuroepithelium is evident. By E8.5, specific tissues and organs of wild-type embryos are distinguishable, including the neural tube, somites, foregut, branchial arches, myocardium, and primitive heart chambers (Fig. 2D). In contrast, the mutant embryos lack somite formation and fail to develop specific tissue types or organs (Fig. 2D). There is also no evidence for formation of the placenta in the mutant embryos, although extraembryonic structures such as the yolk sac and amnion are apparent in the mutants. In addition, the mutant embryos do exhibit some primitive fetal blood formation.
Histologic examination of E7.5 mutant embryos revealed the presence of pyknotic nuclei characterized by condensed chromatin, providing morphologic evidence for apoptosis in the early embryos (Fig. 2E). By E8.5, the presence of pyknotic nuclei throughout the embryo is suggestive of global apoptosis (Fig. 2E). To confirm the presence of apoptosis in the mutant embryos, end-labeling of nucleosome fragments with digoxigenin-UTP by the TUNEL assay was performed. Relative to wild-type littermates, mutant embryos at E7.5 showed significantly increased levels of apoptosis (Fig. 3A). At E8.5, the high levels of apoptosis were particularly striking in the allantois as well as in the head and tail regions of the neuroepithelium (Fig. 3B,C). There was also evidence of apoptosis in the population of fetal hematopoietic cells (Fig. 3C). Together, these data suggest that disruption of the Daxx locus results in extensive apoptosis during embryogenesis.
|
Daxx
/
cell lines exhibit
increased levels of apoptosis
Given the early lethality of the Daxx embryos, derivation of
/
cell lines was essential for further study of
the mutation. Because of the severity and early lethality of the
phenotype, such lines could not be derived from embryonic fibroblasts.
Instead, ES cell lines were established by culturing the inner cell
mass of blastocysts derived from matings of heterozygous
129/SvEv mice. Of 26 cell lines established, 3 were
homozygous mutant at the Daxx locus, as determined by Southern
blot analysis (data not shown). To confirm that the mutant cell lines
were not expressing the wild-type Daxx transcript, Northern
blot analysis was performed on a panel of wild-type and mutant cell
lines. No wild-type transcript (2.4 kb) was present in the
/
cell lines (Fig. 1C). In mutant cell lines, the
wild-type transcript is replaced by a mutant form that migrates at 1.4 kb (Fig. 1C). Homozygous mutant as well as heterozygous embryos were
also found to express this mutant transcript (data not shown). Given
the appearance of this transcript in heterozygotes, which are
phenotypically normal, it is unlikely that the transcript represents a
dominant negative version of Daxx.
Because extensive apoptosis was observed in Daxx mutant embryos, we
were interested in evaluating
Daxx
/
cell lines for evidence
of increased apoptosis. To assess the levels of cell death, wild-type
and mutant cells were fixed, stained with propidium iodide, and
subsequently subjected to FACS analysis. A sub-G1 peak,
comprised of apoptotic cells, was enhanced severalfold in
Daxx
/
relative to Daxx+/+ or
Daxx+/
cell lines (Fig.
4A). FACS analysis following staining with acridine orange revealed a similar increase in the apoptotic population in
mutant versus wild-type cells (data not shown). Following serum starvation of wild-type and mutant cell lines, a proportional increase
in the apoptotic fraction was observed in all cell lines (data not
shown). A DNA fragmentation assay was employed as an additional measure
of apoptosis in the cell lines. As shown in Figure 4B, a DNA laddering
effect was evident in the Daxx
/
cell
lines to a greater extent than in wild-type cells.
|
The observed apoptosis in Daxx-deficient embryos, which is mimicked in
cell lines lacking Daxx, is in contrast to the anticipated phenotype,
namely increased cell survival, were Daxx to play a direct role in
Fas-mediated apoptosis. Targeted disruption of FADD, for example,
results in embryonic lethality, characterized by cardiac defects and
accumulation of erythrocytes (Yeh et al. 1998
; Zhang et al. 1998
),
likely because of a lack of death induction of this particular cell
population. The absence of caspase-8 leads to a comparable phenotype
(Varfolomeev et al. 1998
). Similarly, mutation of Fas, while not
lethal, results in massive production of lymphocytes and liver
hyperplasia (Adachi et al. 1995
, 1996
).
Our findings suggest that Daxx plays an opposite role such that it
prevents apoptosis. However, our data do not distinguish between
apoptosis being a direct effect of the absence of Daxx and a secondary
result of the Daxx mutation. Thus, Daxx may possibly prevent apoptosis
by means of its involvement in a related process, such as DNA damage or
repair. Mutation in the recombinatorial repair gene rad51 (Lim
and Hasty 1996
), for example, results in embryonic lethality at about
the same stage as Daxx and is characterized by increased apoptosis.
Similarly, a mutation in the gene encoding Bloom's helicase (Chester
et al. 1998
) results in significant levels of apoptosis and embryonic
lethality, albeit at a slightly later stage in development.
A role for Daxx in the nucleus
Having initially identified Daxx from a yeast two-hybrid screen
using DNA methyltransferase I as bait, we expected that Daxx would be a
nuclear protein. To address this, we prepared an affinity-purified polyclonal antibody (
-Daxx), the specificity of which was
confirmed by the presence of a 120-kD Daxx band in extracts derived
from wild-type ES cell lines that is absent in Daxx-deficient cell lines (Fig. 5A). Because the
-Daxx antibody also
recognized a nonspecific lower molecular weight band (Fig. 5A), it was
not suitable for use in immunofluorescence experiments.
|
To determine the subcellular localization of Daxx, wild-type ES cells
were fractionated and subsequently immunoprecipitated with
-Daxx.
Western blot analysis with
-Daxx revealed the presence of Daxx
exclusively in the nuclear fraction (Fig. 5B). As a control for the
fractionation procedure, laminin B was shown to be present in the
nuclear fraction as expected (Fig. 5D). Confirming its presence in the
nucleus, Western blot analysis detected Daxx in HeLa nuclear extracts
following immunoprecipitation with
-Daxx but not with an
irrelevant antibody (Fig. 5C).
Our findings support a role for Daxx in the nucleus of the cell. Pluta
et al. (1998)
have also provided evidence suggesting that Daxx may be a
nuclear protein, potentially localized to centromeres during interphase
(Kiriakidou et al. 1997
). The presence of Daxx in the nucleus was
consistent with our having initially identified Daxx as interacting
with DNA methyltransferase I. Moreover, like Daxx, targeted disruption
of the DNA methyltransferase I gene results in early lethality in the
mouse (Li et al. 1992
; Lei et al. 1996
). However, using a number of
different approaches, we have found that Daxx mutant embryos and cell
lines appear to have no defects with respect to either global or
gene-specific methylation (data not shown). It is possible that the
association of Daxx with methylation is secondary to its essential role
in the mouse and/or that there is redundancy among
methylase-associated proteins such as Daxx. Alternatively, given that
Daxx has now been identified in multiple yeast interaction trap screens
with a variety of baits, it is likely that in many of these instances
the identification of Daxx may represent a false positive in the screen.
If Daxx were to physiologically interact with the cytoplasmic domain of
Fas, a membrane-bound molecule, it should be located in the cytoplasm.
In contrast, we show that Daxx is a nuclear and not a cytoplasmic
protein. Our findings may be reconciled with previous data suggesting a
role for Daxx in the induction of Fas-mediated cell death by
recognizing that the high levels of overexpression in such experiments
might not reflect the physiologic activities of the involved proteins.
Alternatively, the effect observed on JNK activation and attributed to
Daxx may be indirect. Finally, the ability of
Fas
-expressing cells to activate JNK may be a
function of signaling through molecules other than Daxx. Our data now
provide in vivo evidence demonstrating that Daxx has an essential role in the
mouse and likely protects from apoptosis at early stages of development.
| |
Materials and methods |
|---|
|
|
|---|
Construction of a targeting vector and generation of germ-line chimeras
The 3'-flanking genomic segment used for the targeting
construct was a 3.5-kb KpnI fragment. Following treatment with
T4 DNA polymerase to create a blunt end, the fragment was cloned into pPNT (Tybulewicz et al. 1991
) that had been digested with XhoI and subsequently treated with the Klenow enzyme. The 5'-flanking segment, a 3.5-kb BamHI fragment, was inserted into the
BamHI site of pPNT. The targeting construct was linearized
with NotI and transfected into TC1 129/SvEv ES
cells (Deng et al. 1996
). Selection and picking of G418 and
FIAU-resistant colonies was essentially as described (Deng et al.
1994
). Southern blot analysis revealed that 7 of 126 clones had
undergone homologous recombination at the Daxx locus. Cells
from clone 17 were microinjected into C57BL/J6
blastocysts followed by transfer into pseudopregnant Swiss Webster
(Taconic) foster mothers. Resulting high-grade agouti chimeras were
mated to 129/SvEv females. Germ-line transmission of the
targeted Daxx allele was predicted by the agouti coat color in the
F1 offspring and confirmed by Southern blot analysis.
Chromosomal localization of mouse Daxx
The Daxx gene was chromosomally mapped using a
SalI fragment from the region immediately downstream of
Daxx (see Fig. 1A). On Southern blots this probe identified
PstI fragments of 2.5 kb in Mus spretus and
C58/J mice and 2.1 kb in NFS/N. Inheritance of these fragments was followed in
the genetic cross (NFS/N × M. spretus) × M.
spretus or C58/J (Adamson et al. 1991
). Genes were
ordered by minimizing the number of recombinants.
PCR analysis
Genotyping of E7.5-E10.5 embryos was performed on genomic DNA
derived from yolk sacs. Genotyping of hematoxylin and eosin-stained sections was performed as described previously (Zeitlin et al. 1995
).
For all PCR reactions, three primers were added simultaneously. Primer
F1 (GTGTACATTAACGAGCTCTGC) corresponds to bp 448-468 of mouse Daxx (sense orientation), a region of exon 2 subject to targeted deletion. Primer R2 (TTCTCCACGGCTCTCAGCAC) corresponds to bp
959-940 (antisense orientation) of Daxx, from the 3' end of exon 2, which is retained at the targeted allele. Primer PNT (GCGAAGGAGCAAAGCTGCTAT) is derived from the 5' end of neo
and is in the antisense orientation. PCR reactions were performed with
Taq polymerase (Boehringer Mannheim) under the following conditions: denaturation at 95°C for 5 min, followed by 30 cycles of
94°C for 20 sec, 60°C for 30 sec, and 72°C for 1 min. Reaction products were electrophoresed on 2% agarose gels.
Northern blot analysis
Total RNA was isolated from NIH-3T3 cells, wild-type ES cells or
/
ES cells using RNA STAT-60 (Tel-Test). ES cells
were grown three or more generations off feeder layers to prevent
feeder cell RNA contamination. Twenty-three micrograms of RNA was
electrophoresed on a 1% formaldehyde agarose gel and transferred to
Genescreen nylon membrane (NEN Life Science Products). The blot was
hybridized with a 32P-labeled (NEN) random-primed
(Stratagene) probe, washed, and exposed to film for 5 days.
Embryo histology and TUNEL assay
Whole embryos were fixed in 4% paraformaldehyde and subsequently embedded in paraffin. Embryo sections of 7-µm thickness were stained with hematoxylin and eosin. TUNEL assay was performed on embryo sections using Apotags (Intergen).
Cell death analysis
ES cells, grown two generations off feeder layers to prevent
feeder cell contamination, were fixed in 70% ethanol.
Low-molecular-weight DNA was extracted at 37°C as described (Ausubel
et al. 1990
). Samples were incubated with RNase A (0.5 mg/ml) and propidium iodide (50 µg/ml),
followed by analysis on a FACS Calibur flow cytometer (Becton-Dickinson).
For DNA fragmentation assay, low-molecular-weight DNA was extracted
from 1 × 107 cells, as described (Grimm and Leder 1997
).
Subcellular fractionation, immunoprecipitation, and Western blotting
Subcellular fractionation of wild-type ES cells was essentially
as described (Chan and Leder 1996
). Immunoprecipitations were performed
using protein A-coupled Sepharose beads (Pierce). Antibodies were
raised (Covance) against an amino-terminal GST fusion protein of Daxx
(amino acids 1-440), and the final bleed was subsequently affinity
purified against amino acids 1-440 of Daxx, which was covalently bound
to cyanogen bromide-activated Sepharose (Pharmacia Biotech). For
Western blots, the affinity-purified
-Daxx antibody was diluted
1:500.
-Laminin B antibody was used at a dilution of 1:2000.
| |
Acknowledgments |
|---|
We thank Cathie Daugherty O'Hara and Anne Harrington for their technical support in generating the Daxx knockout, Juanita Campos-Torres for her assistance with the FACS analysis, and David Conner's helpful advice regarding derivation of ES cells from blastocysts. We are also grateful to Nick Chester, Mark Bedford, and Yasumasa Ishida for their valuable guidance and for critical reading of this manuscript.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked `advertisement' in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
[Key Words: Daxx; yeast two-hybrid; apoptosis; Fas]
Received May 6, 1999; revised version accepted June 16, 1999.
5 Corresponding author.
E-MAIL Leder{at}rascal.med.harvard.edu; FAX (617) 432-7944.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. A. Puto and J. C. Reed Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation Genes & Dev., April 15, 2008; 22(8): 998 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Jung, H.-Y. Kim, J. Kim, M.-G. Lee, J. Pouyssegur, and E. Kim Physical Interactions and Functional Coupling between Daxx and Sodium Hydrogen Exchanger 1 in Ischemic Cell Death J. Biol. Chem., January 11, 2008; 283(2): 1018 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bodai, N. Pardi, Z. Ujfaludi, O. Bereczki, O. Komonyi, E. Balint, and I. M. Boros Daxx-like Protein of Drosophila Interacts with Dmp53 and Affects Longevity and Ark mRNA Level J. Biol. Chem., December 14, 2007; 282(50): 36386 - 36393. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Roubille, S. Combes, J. Leal-Sanchez, C. Barrere;, F. Cransac, C. Sportouch-Dukhan, G. Gahide, I. Serre, E. Kupfer, S. Richard, et al. Myocardial Expression of a Dominant-Negative Form of Daxx Decreases Infarct Size and Attenuates Apoptosis in an In Vivo Mouse Model of Ischemia/Reperfusion Injury Circulation, December 4, 2007; 116(23): 2709 - 2717. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Saffert and R. F. Kalejta Human Cytomegalovirus Gene Expression Is Silenced by Daxx-Mediated Intrinsic Immune Defense in Model Latent Infections Established In Vitro J. Virol., September 1, 2007; 81(17): 9109 - 9120. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. LEROY, J. DEHEUNINCK, S. REVENEAU, B. FOVEAU, Z. JI, C. VILLENET, S. QUIEF, D. TULASNE, J.-P. KERCKAERT, and V. FAFEUR HGF/SF Regulates Expression of Apoptotic Genes in MCF-10A Human Mammary Epithelial Cells Ann. N.Y. Acad. Sci., December 1, 2006; 1090(1): 188 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Croxton, L. A. Puto, I. de Belle, M. Thomas, S. Torii, F. Hanaii, M. Cuddy, and J. C. Reed Daxx Represses Expression of a Subset of Antiapoptotic Genes Regulated by Nuclear Factor-{kappa}B. Cancer Res., September 15, 2006; 66(18): 9026 - 9035. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Muromoto, M. Ishida, K. Sugiyama, Y. Sekine, K. Oritani, K. Shimoda, and T. Matsuda Sumoylation of Daxx Regulates IFN-Induced Growth Suppression of B Lymphocytes and the Hormone Receptor-Mediated Transactivation J. Immunol., July 15, 2006; 177(2): 1160 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Tzeng, Y.-W. Cheng, C.-H. Li, Y.-S. Lin, H.-C. Hsu, and J.-J. Kang Physiological and Functional Interactions between Tcf4 and Daxx in Colon Cancer Cells J. Biol. Chem., June 2, 2006; 281(22): 15405 - 15411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Cantrell and W. A. Bresnahan Human Cytomegalovirus (HCMV) UL82 Gene Product (pp71) Relieves hDaxx-Mediated Repression of HCMV Replication. J. Virol., June 1, 2006; 80(12): 6188 - 6191. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Kwon, M. La, K. H. Oh, Y. M. Oh, G. R. Kim, J. H. Seol, S. H. Baek, T. Chiba, K. Tanaka, O. S. Bang, et al. BTB Domain-containing Speckle-type POZ Protein (SPOP) Serves as an Adaptor of Daxx for Ubiquitination by Cul3-based Ubiquitin Ligase J. Biol. Chem., May 5, 2006; 281(18): 12664 - 12672. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Preston and M. J. Nicholl Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J. Gen. Virol., May 1, 2006; 87(Pt 5): 1113 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Raoul, E. Buhler, C. Sadeghi, A. Jacquier, P. Aebischer, B. Pettmann, C. E. Henderson, and G. Haase Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL PNAS, April 11, 2006; 103(15): 6007 - 6012. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. Zhao, J. Liu, G. S. Sidhu, Y. Niu, Y. Liu, R. Wang, and D. Liao Negative Regulation of p53 Functions by Daxx and the Involvement of MDM2 J. Biol. Chem., November 26, 2004; 279(48): 50566 - 50579. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gostissa, M. Morelli, F. Mantovani, E. Guida, S. Piazza, L. Collavin, C. Brancolini, C. Schneider, and G. Del Sal The Transcriptional Repressor hDaxx Potentiates p53-dependent Apoptosis J. Biol. Chem., November 12, 2004; 279(46): 48013 - 48023. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ishov, O. V. Vladimirova, and G. G. Maul Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX J. Cell Sci., August 1, 2004; 117(17): 3807 - 3820. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Boellmann, T. Guettouche, Y. Guo, M. Fenna, L. Mnayer, and R. Voellmy DAXX interacts with heat shock factor 1 during stress activation and enhances its transcriptional activity PNAS, March 23, 2004; 101(12): 4100 - 4105. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Obradovic, M. Tirard, Zs. Nemethy, O. Hirsch, H. Gronemeyer, and O. F. X. Almeida DAXX, FLASH, and FAF-1 Modulate Mineralocorticoid and Glucocorticoid Receptor-Mediated Transcription in Hippocampal Cells--Toward a Basis for the Opposite Actions Elicited by Two Nuclear Receptors? Mol. Pharmacol., March 1, 2004; 65(3): 761 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Muromoto, K. Sugiyama, A. Takachi, S. Imoto, N. Sato, T. Yamamoto, K. Oritani, K. Shimoda, and T. Matsuda Physical and Functional Interactions between Daxx and DNA Methyltransferase 1-Associated Protein, DMAP1 J. Immunol., March 1, 2004; 172(5): 2985 - 2993. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Hofmann, N. Stollberg, M. L. Schmitz, and H. Will HIPK2 Regulates Transforming Growth Factor-{beta}-Induced c-Jun NH2-Terminal Kinase Activation and Apoptosis in Human Hepatoma Cells Cancer Res., December 1, 2003; 63(23): 8271 - 8277. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. Chen and J. D. Chen Daxx Silencing Sensitizes Cells to Multiple Apoptotic Pathways Mol. Cell. Biol., October 15, 2003; 23(20): 7108 - 7121. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xue, R. Gibbons, Z. Yan, D. Yang, T. L. McDowell, S. Sechi, J. Qin, S. Zhou, D. Higgs, and W. Wang The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies PNAS, September 16, 2003; 100(19): 10635 - 10640. [Abstract] [Full Text] [PDF] |
||||
![]() |
|